Krebs Biochemicals and Industries has informed that the meeting of Board of Directors of the Company is scheduled to be held on Tuesday, 13th February 2018 at Hyderabad to consider and approve the unaudited financial results along with the Limited Review Report for the quarter ended 31st December, 2017; and any other matter with the permission of the Chair. Further, in connection to the declaration of unaudited financial results, trading window for dealing in shares of the Company will remain closed for the specified persons as defined in the Code from 6th February 2018 and shall re-open 48 hours after the publication of the results to the public.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1903.00 |
| Dr. Reddys Labs. | 1353.75 |
| Cipla | 1452.35 |
| Zydus Lifesciences | 1152.90 |
| Lupin | 2489.85 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: